Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019-results from a systematic review and meta-analysis

被引:627
作者
Bauer, Michael [1 ]
Gerlach, Herwig [2 ]
Vogelmann, Tobias [3 ]
Preissing, Franziska [4 ]
Stiefel, Julia [3 ]
Adam, Daniel [4 ]
机构
[1] Univ Klinikum Jena, Klin Anasthesiol & Intens Med, Klinikum 1, D-07747 Jena, Germany
[2] Vivantes Klinikum Neukolln, Rudower Str 48, D-12351 Berlin, Germany
[3] LinkCare GmbH, Kyffhauserstr 64, D-70469 Stuttgart, Germany
[4] CytoSorbents Europe GmbH, Muggelseedamm 131, D-12587 Berlin, Germany
关键词
Sepsis; Septic shock; Mortality; Trend; SOFA; Meta-analysis; INTERNATIONAL CONSENSUS DEFINITIONS; CLINICAL-CRITERIA; GUIDELINES; TRENDS;
D O I
10.1186/s13054-020-02950-2
中图分类号
R4 [临床医学];
学科分类号
100218 [急诊医学];
摘要
Background Sepsis and septic shock remain drivers for mortality in critically ill patients. The heterogeneity of the syndrome hinders the generation of reproducible numbers on mortality risks. Consequently, mortality rates range from 15 to 56%. We aimed to update and extend the existing knowledge from meta-analyses and estimate 30- and 90-day mortality rates for sepsis and septic shock separately, stratify rates by region and study type and assess mortality rates across different sequential organ failure assessment (SOFA) scores. Methods We performed a systematic review of articles published in PubMed or in the Cochrane Database, between 2009 and 2019 in English language including interventional and observational studies. A meta-analysis of pooled 28/30- and 90-day mortality rated separately for sepsis and septic shock was done using a random-effects model. Time trends were assessed via Joinpoint methodology and for the assessment of mortality rate over different SOFA scores, and linear regression was applied. Results Four thousand five hundred records were identified. After title/abstract screening, 783 articles were assessed in full text for eligibility. Of those, 170 studies were included. Average 30-day septic shock mortality was 34.7% (95% CI 32.6-36.9%), and 90-day septic shock mortality was 38.5% (95% CI 35.4-41.5%). Average 30-day sepsis mortality was 24.4% (95% CI 21.5-27.2%), and 90-day sepsis mortality was 32.2% (95% CI 27.0-37.5%). Estimated mortality rates from RCTs were below prospective and retrospective cohort studies. Rates varied between regions, with 30-day septic shock mortality being 33.7% (95% CI 31.5-35.9) in North America, 32.5% (95% CI 31.7-33.3) in Europe and 26.4% (95% CI 18.1-34.6) in Australia. A statistically significant decrease of 30-day septic shock mortality rate was found between 2009 and 2011, but not after 2011. Per 1-point increase of the average SOFA score, average mortality increased by 1.8-3.3%. Conclusion Trends of lower sepsis and continuous septic shock mortality rates over time and regional disparities indicate a remaining unmet need for improving sepsis management. Further research is needed to investigate how trends in the burden of disease influence mortality rates in sepsis and septic shock at 30- and 90-day mortality over time.
引用
收藏
页数:9
相关论文
共 30 条
[1]
[Anonymous], 2018, Sepsis
[2]
DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[3]
Severe Sepsis and Septic Shock REPLY [J].
Angus, Derek C. ;
van der Poll, Tom .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (21) :2063-2063
[4]
Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]
[5]
The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial [J].
Elke, Gunnar ;
Bloos, Frank ;
Wilson, Darius Cameron ;
Brunkhorst, Frank Martin ;
Briegel, Josef ;
Reinhart, Konrad ;
Loeffler, Markus ;
Kluge, Stefan ;
Nierhaus, Axel ;
Jaschinski, Ulrich ;
Moerer, Onnen ;
Weyland, Andreas ;
Meybohm, Patrick .
CRITICAL CARE, 2018, 22
[6]
Benchmarking the Incidence and Mortality of Severe Sepsis in the United States [J].
Gaieski, David F. ;
Edwards, J. Matthew ;
Kallan, Michael J. ;
Carr, Brendan G. .
CRITICAL CARE MEDICINE, 2013, 41 (05) :1167-1174
[7]
Kinetics of circulating fetuin-A may predict mortality independently from adiponectin, high molecular weight adiponectin and prognostic factors in critically ill patients with sepsis: A prospective study [J].
Karampela, Irene ;
Kandri, Evangelia ;
Antonakos, Georgios ;
Vogiatzakis, Evangelos ;
Christodoulatos, Gerasimos Socrates ;
Nikolaidou, Athina ;
Dimopoulos, George ;
Armaganidis, Apostolos ;
Dalamaga, Maria .
JOURNAL OF CRITICAL CARE, 2017, 41 :78-85
[8]
Mortality Related to Severe Sepsis and Septic Shock Among Critically III Patients in Australia and New Zealand, 2000-2012 [J].
Kaukonen, Kirsi-Maija ;
Bailey, Michael ;
Suzuki, Satoshi ;
Pilcher, David ;
Bellomo, Rinaldo .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (13) :1308-1316
[9]
Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO
[10]
2-Q